January « 2014 « Science and Enterprise

Trial Shows Gene Therapy Helps Treat Genetic Eye Disease

By Alan, on January 16th, 2014%

Robert MacLaren (University of Oxford)

Researchers at University of Oxford in the U.K. report initial results of a clinical trial showing healthy genes injected into the retinas of patients with a rare inherited disease improved their vision after six months. Findings from the study led by Oxford eye surgeon Robert MacLaren are published . . . → Read More: Trial Shows Gene Therapy Helps Treat Genetic Eye Disease

Biotech, National Lab Partner on Gas-to-Liquid Conversion

By Alan, on January 15th, 2014%

(NOAA.gov)

Calysta Energy, a biotechnology company in Menlo Park, California and Lawrence Livermore National Laboratory in Livermore, California are developing a biological process for converting methane to liquid fuel. Financial aspects of the agreement were not disclosed. Livermore National Lab is a facility of the U.S. Department of Energy.

The project aims to . . . → Read More: Biotech, National Lab Partner on Gas-to-Liquid Conversion

South Carolina Partnership Licenses First Technology

By Alan, on January 15th, 2014%

(Mikael Häggström/Wikimedia Commons)

SCRA, a South Carolina state business investment organization in Columbia, and TAO Life Sciences, a medical device commercialization company in Greenville, say they completed their first licensing deal for a chest drainage tube device invented by students at Clemson University. Financial aspects of the licensing agreement were not disclosed.

Bioengineering . . . → Read More: South Carolina Partnership Licenses First Technology

Institutes Developing Power Grid Cybersecurity Technology

By Alan, on January 14th, 2014%

(Brookhaven National Lab)

Engineering labs at Georgia Institute of Technology in Atlanta are designing a suite of tools to better protect electric power grids, incorporating lessons from recent smart grid developments. The $1.7 million grant from U.S. Department of Energy will fund the work of the Georgia Tech Research Institute, with two other . . . → Read More: Institutes Developing Power Grid Cybersecurity Technology

Regeneron, Geisinger Health to Partner on Genetic Sequencing

By Alan, on January 14th, 2014%

(NIST.gov)

Regeneron Pharmaceuticals Inc. in Tarrytown, New York and Geisinger Health System, a health care provider in Pennsylvania, are studying genetic causes of disease among the 2.6 million residents in areas served by Geisinger’s facilities. Financial terms of the five-year agreement were not disclosed.

Under the deal, Geisinger will collect blood specimens from . . . → Read More: Regeneron, Geisinger Health to Partner on Genetic Sequencing

Clinical Trial to Test Safety of MRSA Drug Candidate

By Alan, on January 13th, 2014%

Scanning electron micrograph image of MRSA bacteria (Janice Haney Carr, Centers for Disease Control and Prevention)

Enanta Pharmaceuticals, a biotechnology company in Watertown, Massachusetts, is starting an early-stage clinical trial of an antibiotic to treat methicillin-resistant Staphylococcus aureus or MRSA infections. The drug, code-named EDP-788, is being developed under a contract with National . . . → Read More: Clinical Trial to Test Safety of MRSA Drug Candidate

Trial Testing Ultrasound Technique to Move Kidney Stones

By Alan, on January 10th, 2014%

Mike Bailey (University of Washington)

A clinical trial at University of Washington in Seattle is testing an ultrasound device that moves the position of kidney stones in the body to encourage safe passage of the stones without surgery. The early-stage trial is testing the device invented in the lab of engineering professor Mike Bailey, . . . → Read More: Trial Testing Ultrasound Technique to Move Kidney Stones

DNA Diagnostics Company to Crowdfund Malaria Testing Device

By Alan, on January 10th, 2014%

Q-POC device (QuantuMDx Group)

QuantuMDx, a biotechnology company in Newcastle, U.K. says it will start a crowdfunding campaign next month to finance development and field trials of a handheld device to test for malaria. The device is an application of its Q-POC point-of-care diagnostics system, which will be the subject of an Indiegogo campaign . . . → Read More: DNA Diagnostics Company to Crowdfund Malaria Testing Device

UCSF, Quest Diagnostics to Partner on Precision Medicine

By Alan, on January 9th, 2014%

(Univ of California, San Francisco)

Medical diagnostics provider Quest Diagnostics in Madison, New Jersey and University of California in San Francisco are researching new tests based on genetic and molecular indicators to better find genetic causes of developmental disorders like autism, and identify children with brain tumors who can best respond to treatments. The . . . → Read More: UCSF, Quest Diagnostics to Partner on Precision Medicine

Heart Vessel Surgical Glue Shown Effective in Animal Tests

By Alan, on January 9th, 2014%

(NASA.gov)

Surgeons and biomedical engineers at Boston Children’s and Brigham and Women’s hospitals and Massachusetts Institute of Technology, developed a non-toxic, biocompatible surgical glue that in tests with pigs patches heart defects, such as those in large blood vessels. The team led by Boston Children’s Pedro del Nido and Jeffrey Karp of Brigham . . . → Read More: Heart Vessel Surgical Glue Shown Effective in Animal Tests

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise